• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖和 Roux-en-Y 胃旁路手术导致人直肠黏膜中 miR-31 和 miR-215 的表达发生变化。

Obesity and Roux-en-Y gastric bypass drive changes in miR-31 and miR-215 expression in the human rectal mucosa.

机构信息

Human Nutrition Research Centre, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.

Biosciences Institute, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.

出版信息

Int J Obes (Lond). 2022 Feb;46(2):333-341. doi: 10.1038/s41366-021-01005-y. Epub 2021 Oct 29.

DOI:10.1038/s41366-021-01005-y
PMID:34716428
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8794786/
Abstract

BACKGROUND/OBJECTIVES: Obesity increases colorectal cancer (CRC) risk. However, the effects of weight loss on CRC risk are unclear. Epigenetic mechanisms involving microRNAs that lead to dysregulated gene expression may mediate the effects of obesity and weight loss on CRC risk. We examined the effects of obesity and weight loss following Roux-en-Y gastric bypass (RYGB) on microRNA expression in the human rectal mucosa.

SUBJECTS/METHODS: We collected rectal mucosal biopsies from obese patients (n = 22) listed for RYGB and age- and sex-matched healthy non-obese Controls (n = 20), at baseline and six months post-surgery. We quantified microRNA expression in rectal mucosal biopsies using Next Generation Sequencing and bioinformatics analysis to investigate the likely functional consequences of these epigenetic changes.

RESULTS

Compared with non-obese individuals, obese individuals showed differential expression of 112 microRNAs (p < 0.05). At six-months post-RYGB, when mean body mass had fallen by 27 kg, 60 microRNAs were differentially expressed, compared with baseline (p < 0.05). The expression of 36 microRNAs differed significantly between both i) obese and non-obese individuals and ii) obese individuals pre- and post-RYGB. Quantitative polymerase chain reaction (qPCR) demonstrated that expression of miR-31 and miR-215 was significantly (p < 0.05) higher, 143-fold and 15-fold respectively, in obese than in non-obese individuals. Weight loss, following RYGB, reduced expression of miR-31 and miR-215 to levels comparable with Controls. These differentially expressed microRNAs are implicated in pathways linked with inflammation, obesity and cancer.

CONCLUSION

Our findings show, for the first time, that obesity is associated with dysregulated microRNA expression in the human rectal mucosa. Further, surgically-induced weight loss may normalise microRNA expression in this tissue.

摘要

背景/目的:肥胖会增加结直肠癌(CRC)的风险。然而,减肥对 CRC 风险的影响尚不清楚。涉及 microRNA 的表观遗传机制可能导致基因表达失调,从而介导肥胖和减肥对 CRC 风险的影响。我们研究了肥胖和 Roux-en-Y 胃旁路手术后(RYGB)减肥对人直肠黏膜中 microRNA 表达的影响。

受试者/方法:我们收集了 22 名接受 RYGB 治疗的肥胖患者(肥胖组)和 20 名年龄和性别匹配的健康非肥胖对照者(对照组)的直肠黏膜活检组织,分别在基线和术后 6 个月时采集。我们使用下一代测序和生物信息学分析来定量直肠黏膜活检组织中的 microRNA 表达,以研究这些表观遗传变化的可能功能后果。

结果

与非肥胖个体相比,肥胖个体的 112 种 microRNA 表达存在差异(p<0.05)。在 RYGB 术后 6 个月时,当平均体重下降 27kg 时,与基线相比,有 60 种 microRNA 表达发生差异(p<0.05)。肥胖和非肥胖个体之间以及肥胖个体术前和术后之间存在显著差异的 microRNA 表达有 36 种。定量聚合酶链反应(qPCR)显示,与非肥胖个体相比,miR-31 和 miR-215 的表达分别高出 143 倍和 15 倍(p<0.05)。RYGB 后的体重减轻使 miR-31 和 miR-215 的表达降低到与对照组相当的水平。这些差异表达的 microRNA 与炎症、肥胖和癌症相关的途径有关。

结论

我们的研究结果首次表明,肥胖与人类直肠黏膜中 microRNA 表达失调有关。此外,手术诱导的体重减轻可能使该组织中的 microRNA 表达恢复正常。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/c8f1f1b403f0/41366_2021_1005_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/f0d384f3655a/41366_2021_1005_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/8174dfed84ae/41366_2021_1005_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/131c869cea51/41366_2021_1005_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/780aeba9b4a5/41366_2021_1005_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/c8f1f1b403f0/41366_2021_1005_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/f0d384f3655a/41366_2021_1005_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/8174dfed84ae/41366_2021_1005_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/131c869cea51/41366_2021_1005_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/780aeba9b4a5/41366_2021_1005_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/afd2/8794786/c8f1f1b403f0/41366_2021_1005_Fig5_HTML.jpg

相似文献

1
Obesity and Roux-en-Y gastric bypass drive changes in miR-31 and miR-215 expression in the human rectal mucosa.肥胖和 Roux-en-Y 胃旁路手术导致人直肠黏膜中 miR-31 和 miR-215 的表达发生变化。
Int J Obes (Lond). 2022 Feb;46(2):333-341. doi: 10.1038/s41366-021-01005-y. Epub 2021 Oct 29.
2
Biomarkers of Colorectal Cancer Risk Decrease 6 months After Roux-en-Y Gastric Bypass Surgery.结直肠癌风险生物标志物在Roux-en-Y胃旁路手术后6个月降低。
Obes Surg. 2018 Apr;28(4):945-954. doi: 10.1007/s11695-017-2953-6.
3
Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased 3 years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: implications for long-term neoplastic risk following RYGB.直肠上皮细胞有丝分裂和巨噬细胞移动抑制因子的表达在病态肥胖行 Roux-en-Y 胃旁路术(RYGB) 3 年后增加:对 RYGB 后长期肿瘤风险的影响。
Gut. 2011 Jul;60(7):893-901. doi: 10.1136/gut.2010.230755. Epub 2011 Feb 8.
4
Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and roux-en-Y gastric bypass.与肥胖症和Roux-en-Y胃旁路手术相关的结肠直肠上皮细胞增殖增加和隐窝裂变。
Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1401-10. doi: 10.1158/1055-9965.EPI-07-2874.
5
Gastric bypass surgery with exercise alters plasma microRNAs that predict improvements in cardiometabolic risk.胃旁路手术联合运动可改变血浆微小RNA,这些微小RNA可预测心血管代谢风险的改善情况。
Int J Obes (Lond). 2017 Jul;41(7):1121-1130. doi: 10.1038/ijo.2017.84. Epub 2017 Mar 27.
6
The Long-term Impact of Roux-en-Y Gastric Bypass on Colorectal Polyp Formation and Relation to Weight Loss Outcomes.Roux-en-Y 胃旁路术对结直肠息肉形成的长期影响及其与减重效果的关系。
Obes Surg. 2020 Feb;30(2):407-415. doi: 10.1007/s11695-019-04176-w.
7
High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity.肥胖症患者行 Roux-en-Y 胃旁路手术后高密度脂蛋白相关 microRNA 水平升高。
J Lipid Res. 2021;62:100043. doi: 10.1194/jlr.RA120000963. Epub 2021 Feb 6.
8
Haematological indices and haematinic levels after mini gastric bypass: a matched comparison with Roux-en-Y gastric bypass.迷你胃旁路术后的血液学指标和造血素水平:与Roux-en-Y胃旁路术的配对比较。
Clin Obes. 2018 Feb;8(1):43-49. doi: 10.1111/cob.12227. Epub 2017 Oct 23.
9
Weight loss after Roux-En-Y gastric bypass surgery reveals skeletal muscle DNA methylation changes.胃旁路手术后体重减轻揭示骨骼肌 DNA 甲基化变化。
Clin Epigenetics. 2021 May 1;13(1):100. doi: 10.1186/s13148-021-01086-6.
10
Alterations of sorbin and SH3 domain containing 3 (SORBS3) in human skeletal muscle following Roux-en-Y gastric bypass surgery.Roux-en-Y 胃旁路手术后人类骨骼肌中 sorbin 和含 SH3 结构域蛋白 3(SORBS3)的改变。
Clin Epigenetics. 2017 Sep 2;9:96. doi: 10.1186/s13148-017-0396-5. eCollection 2017.

引用本文的文献

1
Epigenetic modifications in obesity-associated diseases.肥胖相关疾病中的表观遗传修饰。
MedComm (2020). 2024 Feb 24;5(2):e496. doi: 10.1002/mco2.496. eCollection 2024 Feb.
2
Distinctive patterns of sulfide- and butyrate-metabolizing bacteria after bariatric surgery: potential implications for colorectal cancer risk.减重手术后硫和丁酸盐代谢菌的独特模式:对结直肠癌风险的潜在影响。
Gut Microbes. 2023 Dec;15(2):2255345. doi: 10.1080/19490976.2023.2255345.
3
Pathophysiology of obesity and its associated diseases.肥胖及其相关疾病的病理生理学

本文引用的文献

1
Improved physiology and metabolic flux after Roux-en-Y gastric bypass is associated with temporal changes in the circulating microRNAome: a longitudinal study in humans.Roux-en-Y胃旁路术后生理功能和代谢通量的改善与循环微小RNA组的时间变化相关:一项人类纵向研究。
BMC Obes. 2018 May 31;5:20. doi: 10.1186/s40608-018-0199-z. eCollection 2018.
2
MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9.MiR-215-5p是一种结直肠癌中的肿瘤抑制因子,其作用靶点为表皮生长因子受体(EGFR)配体上皮调节蛋白及其转录诱导因子HOXB9。
Oncogenesis. 2017 Dec 4;6(11):399. doi: 10.1038/s41389-017-0006-6.
3
Acta Pharm Sin B. 2023 Jun;13(6):2403-2424. doi: 10.1016/j.apsb.2023.01.012. Epub 2023 Jan 13.
4
Change Profiles and Functional Targets of MicroRNAs in Type 2 Diabetes Mellitus Patients with Obesity.2 型糖尿病肥胖患者中 microRNAs 的变化特征和功能靶标。
Diabetes Metab J. 2023 Jul;47(4):559-570. doi: 10.4093/dmj.2022.0226. Epub 2023 Apr 25.
5
Circulating microRNAs Showed Specific Responses according to Metabolic Syndrome Components and Sex of Adults from a Population-Based Study.基于人群的研究表明,循环微小RNA根据成人的代谢综合征组分和性别呈现出特定反应。
Metabolites. 2022 Dec 20;13(1):2. doi: 10.3390/metabo13010002.
6
Using ncRNAs as Tools in Cancer Diagnosis and Treatment-The Way towards Personalized Medicine to Improve Patients' Health.利用 ncRNAs 作为癌症诊断和治疗的工具——迈向改善患者健康的个体化医疗之路。
Int J Mol Sci. 2022 Aug 19;23(16):9353. doi: 10.3390/ijms23169353.
The p53 isoform delta133p53ß regulates cancer cell apoptosis in a RhoB-dependent manner.
p53 异构体 delta133p53β 以 RhoB 依赖的方式调节癌细胞凋亡。
PLoS One. 2017 Feb 17;12(2):e0172125. doi: 10.1371/journal.pone.0172125. eCollection 2017.
4
Concordant and discordant regulation of target genes by miR-31 and its isoforms.miR-31 及其异构体对靶基因的协调和不协调性调节。
PLoS One. 2013;8(3):e58169. doi: 10.1371/journal.pone.0058169. Epub 2013 Mar 5.